Generic Pharmaceuticals Businesses for Sale and Investment

• Established generic pharmaceutical manufacturing unit located in Hyderabad, operational for over 5 years. • Built-up area of 60,000 sq. ft. across 4 floors, each dedicated to specific product lines (tablets, capsules, syrups and powders). • Licensed for manufacturing 300+ medicines and holds GMP certification. • Expansion potential to INR 12–15 crore annually with sufficient working capital infusion. • In-house distribution house established, supported by third-party manufacturing orders. • Current output: 10,000 tablets/day and 500 liters syrup/day with 1 batch/day. • Installed capacity allows up to 3 batches/day for significantly higher production. • Open to outright sale, partial stake (10–80%), or long lease arrangements.

State-of-the-art pharmaceutical R&D facility located in Verna Industrial Estate, South Goa a prime pharma corridor near ports and airports and home to top pharma companies like Pfizer, Cipla, Sanofi, Abbott, and Colorcon. - Fully equipped, ready-to-operate 3-floor R&D building with dedicated areas for administration, formulation development, and analytical development; upcoming 4-floor Pilot Manufacturing building beside R&D. - FDA approval from the State of Goa, enabling immediate start of operations with necessary licenses and compliance for both domestic and international markets. - It is a land of 1,800 m² space with 24/7 CCTV, controlled access, a robust electric supply, water purification systems, ETP-certified waste management, and fire safety compliance. The promoter holds permission for subleasing the property. - Formulation lab fitted with clean rooms, HVAC & AHU systems, HEPA filters, and equipment including high-shear granulators, fluid bed dryers, nano-milling systems, spray drying tech, multi-layer tablet press, and encapsulation machines. - Analytical lab equipped with advanced instruments such as Malvern Mastersizer, UHPLC, FTIR, DSC, dissolution apparatus, and gas chromatography systems; stability chambers for long-term studies. - The administration area includes open workspaces, conference and meeting rooms, reception, and executive cabins for quality, regulatory, and operational teams. - Additional features: 800 KVA transformer, 380 KVA diesel generator (CPCB-II certified), 160 KVA UPS backup, rainwater drainage, ample parking, and logistics-friendly loading bays. - Offered on a turnkey, long-term lease basis with all machinery and infrastructure included from Day 1, ensuring cost-effective setup and rapid operational launch. Tangible assets: 22,000 sq. ft. of fully equipped 3-floor R&D building, upcoming 4-floor pilot manufacturing unit, advanced formulation machineries, analytical instruments, clean rooms, HVAC and AHU systems, power backup infrastructure, water purification and waste management systems, fire safety systems, furniture and fixtures, surveillance systems, parking, loading bay, borewell, and drainage facilities. Intangible assets: FDA approval assistance, regulatory-ready infrastructure, prime industrial location with logistics advantages, electronic laboratory notebook and data integrity systems, strong industry reputation, and strategic lease with quick setup benefits.

Engaged in pharmaceutical manufacturing, supplying tablets and capsules to both domestic and international markets. - Operates from an 18,000 sq. ft. constructed manufacturing facility located in Gujarat. - The facility supports a monthly production of approximately 4 crore tablets/capsules. - Holds a valid drug license and GST registration, Exim license, ensuring regulatory compliance for manufacturing and distribution. - Business model centers on contract manufacturing and long-term partnerships with pharma companies. - Team includes experienced professionals with technical and regulatory expertise in pharma manufacturing and export compliance.

Located in Kolkata, this pharmaceutical company specializes in manufacturing a range of pharmaceutical products. - Primary products include liquid syrups, suspensions, tablets, capsules, eye drops, and oral solutions. - Supplies its products primarily to distributors and pharmacies in West Bengal and other states such as Bihar, Odisha, Assam, Jharkhand, and North-East India. - Production capabilities include 5,000-20,000 units of liquid syrups and suspensions per month, 100,000-300,000 tablets monthly, and 2,000-5,000 eye drops and oral solutions each month. - Verified seller on TradeIndia, renowned for providing high-quality pharmaceutical syrups and tablets. - The company is not USFDA approved but has a valid drug license under the Department of Health and Family Welfare, Government of West Bengal.

The company is a WHO GMP standard pharmaceutical firm located in Hinganghat, referred to as the center of India, positioning it strategically for robust distribution. - We specialize in manufacturing high-quality generic drugs, focusing specifically on tablet and capsule forms to cater to a wide range of healthcare needs. - With an impressive manufacturing capacity, the company can produce up to 40 lakh tablets per day, ensuring the ability to meet both domestic and international demand efficiently. - As an FDA-approved entity in the countries where they export, the business adheres to stringent quality regulations, enhancing their credibility and reliability on a global scale. - The business predominantly generates revenue through exports, supported by approvals from NAFDAC, Ghana, and Uzbek FDA, indicating strong international market presence. - Operating on a job work model, the company collaborates with over 10 merchant exporters who have registered products, demonstrating robust partnerships in the pharmaceutical export industry. - The promoters bring over 25 years of combined experience, underscoring the business's depth in pharmaceutical industry knowledge and operational prowess. - There are 80 permanent employees, with additional contract or temporary staff hired for manufacturing and logistics based on operational needs and demand.

Based in Pune, this pharmaceutical business specializes in the distribution of multiple antibiotic brands. - The company's top-selling products, Meropenem and Ertapenem, are distributed to traders, hospitals, and pharmacists, showcasing a diverse customer base within the generic pharmaceuticals industry. - The business experiences seasonality in sales but anticipates doubling its revenue during peak seasons over the next few months. - Currently, the company caters to 4 to 5 main customers, highlighting the need for investment to expand its customer base and increase market penetration. - The business plans to establish an antibiotic vial manufacturing unit, targeting a production capacity of 70k vials per day, aiming to become a contract manufacturer for leading pharmaceutical brands. - With a confirmed working order worth INR 4 crore, the company is poised to boost production and considers international export as a strategic growth area, offering significant investment potential. - The business holds a drug license, ensuring compliance with regulatory standards. The FDA license process is currently underway.

Situated in Kala Amb, an industrial hub, providing prime access to suppliers and customers in the generic pharmaceuticals market. - With operations focusing on repackaging medicines and chemicals alongside a rental income of INR 80,000 per month from a manufacturing business, ensures a steady cash flow. - Holds a valid repacking license that allows easy adaptation and potential for pivoting into alternative business ventures within the pharmaceuticals sector. - Equipped with a GST certificate, facilitating smooth and compliant operations in the pharmaceutical repackaging market. - Supplies repackaged generic medicines directly to government hospitals, securing a stable and recurrent client base in the healthcare industry. - Investors have the option to alter the existing license to diversify offerings or explore new verticals, enhancing growth prospects in the booming generic medicines domain.

The tangible assets include 2 empty gelatin capsule-making machinery. The machines are in good working condition and have been well maintained. Each machine is worth almost INR 1.6 crore.